J. L. Perez-Gracia - Dept Oncol, Univ Clin Navarra

基本信息

浏览量：0

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 63 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Induction Avelumab Followed by Chemoimmunotherapy and Maintenance Versus Chemotherapy Alone As First-Line Therapy in Cis-Ineligible Metastatic Urothelial Carcinoma (INDUCOMAIN): a Randomized Phase II Study

A. Rodriguez-Vida,B. P. Valderrama, D. Castellano, A. Pinto, B. Mellado, J. Puente, M. A. Climent, M. Domenech, F. Vazquez,J. L. Perez-Gracia,T. Bonfill,R. Morales-Barrera,E. Gonzalez-Billalabeitia, X. Garcia-del-Muro,P. Maroto, N. Navarro-Gorro,N. Juanpere, O. Juan,J. Bellmunt

ESMO Openno. 9 (2024): 103690-103690

引用0浏览0WOS引用

Streamlining Clinical Research: an ESMO Awareness Call to Improve Sponsoring and Monitoring of Clinical Trials

J. L. Perez-Gracia,N. Penel,E. Calvo,A. Awada,H. T. Arkenau,T. Amaral,V. Gruenwald,M. F. Sanmamed,L. Castelo-Branco,G. Bodoky,M. P. Lolkema,M. Di Nicola,P. Casali,R. Giuliani,G. Pentheroudakis

ANNALS OF ONCOLOGY（2023）

引用6浏览0WOS引用

Reply to Letter to the Editor "bureaucracy or Streamlining the Rules in "good Clinical Practice (GCP)" - Has Equipoise Occurred?" by H. K. Kotikonda, V. G. Jonnalagadda and S. R. Venna

J L Perez-Gracia,N Penel,E Calvo,H T Arkenau,T Amaral,V Grünwald,M F Sanmamed

Annals of oncology official journal of the European Society for Medical Oncologyno. 5 (2023): 498-499

引用1浏览0WOS引用

579MO CheckMate 9KD Cohort A2 Final Analysis: Nivolumab (NIVO) + Rucaparib for Chemotherapy (Ct)-Naïve Metastatic Castration-Resistant Prostate Cancer (Mcrpc)

D.P. Petrylak,J.L. Perez-Gracia,L. Lacombe,D.A. Bastos,H. Mahammedi,E.M. Kwan,S. Zschäbitz,A.J. Armstrong, R.K. Pachynski,J.C. Goh,M. Burotto,G. Gravis,S.L. McCune,J.C. Vázquez Limón,M. Retz,F. Saad,N.P. Amin,J. Li,K. Unsal-Kacmaz,K. Fizazi

Annals of oncology (2021): S629-S630

引用17浏览0引用

5-Year Survival Update From Keynote-010: Pembrolizumab Versus Docetaxel In Previously Treated, Pd-L1-Positive Advanced Nsclc

R. Herbst,E. Garon,D. Kim,B. C. Cho,R. Gervais,J. L. Perez-Gracia,J. Han,M. Majem,M. D. Forster,I. Monnet,S. Novello,M. A. Gubens,M. Boyer,W. Su,A. Samkari, E. H. Jensen,B. Piperdi,P. Baas

JOURNAL OF THORACIC ONCOLOGY（2021）

引用6浏览0引用

P12.03 the Time of Anti-PD-1 Infusion Improves Survival Outcomes by Fasting Conditions Simulation in Non-Small Cell Lung Cancer

A. Vilalta-Lacarra,M. Rodriguez-Remirez, I. Lopez-Erdozain,A. Puyalto,I. Baraibar,J. Corral,A. Gúrpide,J.M. López-Picazo,J.L. Pérez-Gracia,M.P. Andueza,V. Catalan,G. Fruhbeck,R. Pio,D. Ajona, I. Gil-Bazo

Journal of thoracic oncologyno. 10 (2021): S1007-S1008

引用0浏览0引用

FP13.01 5-Year Survival Update from KEYNOTE-010: Pembrolizumab Versus Docetaxel in Previously Treated, PD-L1–Positive Advanced NSCLC

R. Herbst,E. Garon, D. Kim,B.C. Cho,R. Gervais,J.L. Perez-Gracia,J. Han,M. Majem,M.D. Forster,I. Monnet,S. Novello,M.A. Gubens,M. Boyer,W. Su,A. Samkari,E.H. Jensen,B. Piperdi,P. Baas

Journal of thoracic oncologyno. 3 (2021): S223-S224

引用5浏览0引用

Beyond the Lessons Learned from the COVID-19 Pandemic: Opportunities to Optimize Clinical Trial Implementation in Oncology

L. Castelo-Branco,A. Awada,G. Pentheroudakis,J.L. Perez-Gracia,J. Mateo,G. Curigliano,S. Banerjee,R. Giuliani,F. Lordick,A. Cervantes,J. Tabernero,S. Peters

ESMO Open（2021）

引用10浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn